Your browser is no longer supported. Please, upgrade your browser.
Settings
ONCE Spark Therapeutics, Inc. daily Stock Chart
ONCE [NASD]
Spark Therapeutics, Inc.
Index- P/E- EPS (ttm)-6.55 Insider Own7.45% Shs Outstand38.19M Perf Week0.09%
Market Cap4.23B Forward P/E- EPS next Y-5.27 Insider Trans0.00% Shs Float36.09M Perf Month-0.56%
Income-250.40M PEG- EPS next Q-1.71 Inst Own90.70% Short Float9.80% Perf Quarter5.68%
Sales69.90M P/S60.51 EPS this Y72.30% Inst Trans1.54% Short Ratio6.60 Perf Half Y11.09%
Book/sh8.93 P/B12.40 EPS next Y20.20% ROA-33.10% Target Price105.12 Perf Year181.95%
Cash/sh10.21 P/C10.85 EPS next 5Y17.00% ROE-59.10% 52W Range34.53 - 114.20 Perf YTD182.96%
Dividend- P/FCF- EPS past 5Y2.90% ROI-35.40% 52W High-3.02% Beta2.03
Dividend %- Quick Ratio4.30 Sales past 5Y- Gross Margin82.90% 52W Low220.74% ATR1.04
Employees368 Current Ratio4.70 Sales Q/Q109.30% Oper. Margin- RSI (14)57.97 Volatility0.98% 0.87%
OptionableYes Debt/Eq0.14 EPS Q/Q-36.10% Profit Margin- Rel Volume1.44 Prev Close110.55
ShortableYes LT Debt/Eq0.12 EarningsNov 26 Payout- Avg Volume536.14K Price110.75
Recom3.00 SMA20-0.28% SMA503.29% SMA2004.74% Volume770,383 Change0.18%
Feb-25-19Downgrade Cantor Fitzgerald Overweight → Neutral $80 → $114.50
Jan-10-19Reiterated Cantor Fitzgerald Overweight $103 → $80
Nov-16-18Upgrade Credit Suisse Underperform → Neutral
Nov-07-18Upgrade Wedbush Underperform → Neutral $40
Nov-07-18Upgrade Raymond James Outperform → Strong Buy
Nov-07-18Upgrade B. Riley FBR Neutral → Buy $68 → $71
Oct-10-18Initiated Guggenheim Buy
Aug-08-18Reiterated Stifel Buy $76 → $68
Aug-08-18Reiterated Chardan Capital Markets Neutral $60 → $85
Aug-07-18Upgrade Citigroup Neutral → Buy
Aug-07-18Downgrade Credit Suisse Outperform → Underperform
Jul-19-18Downgrade RBC Capital Mkts Outperform → Sector Perform
Jun-28-18Initiated B. Riley FBR, Inc. Neutral $74
May-09-18Reiterated Barclays Overweight $64 → $85
May-01-18Initiated Citigroup Neutral $85
Apr-23-18Downgrade Chardan Capital Markets Buy → Neutral $80 → $85
Feb-21-18Reiterated Stifel Buy $73 → $64
Feb-14-18Downgrade JP Morgan Overweight → Neutral
Feb-13-18Initiated Mizuho Buy $79
Feb-08-18Resumed RBC Capital Mkts Outperform $65
Dec-09-19 10:16AM  Week Begins with Biotech Mergers Zacks
10:09AM  Make it 10: Roche again extends $4.3B bid to buy Spark Therapeutics American City Business Journals
10:06AM  Merger Monday, Biotech Edition: MRK, SNY, ARQL, THOR & More Zacks
05:30AM  European stocks struggle, with drugmakers weaker and Tullow Oil plunging MarketWatch
04:08AM  Roche extends tender offer for Spark Therapeutics MarketWatch
01:13AM  Swiss drugmaker Roche again extends $4.3 bln Spark offer until Dec. 16 Reuters
Dec-05-19 04:54PM  John Paulson's Top 5 Buys in the 3rd Quarter GuruFocus.com
Dec-03-19 02:46PM  Is Spark Therapeutics Inc (ONCE) A Good Stock To Buy? Insider Monkey
11:11AM  Astellas $3 billion gene therapy deal steadies investors after stalled Roche acquisition MarketWatch
09:31AM  Gene-Therapy Firm Audentes Sells for Double Its Share Price. It Could Be the First of Many More Deals. Barrons.com
Dec-02-19 02:57PM  7 Exciting Biotech Stocks to Buy Now InvestorPlace
Nov-22-19 11:44AM  Roche's $4.3B tender offer for Spark is extended yet again American City Business Journals
10:29AM  BioMarin Files MAA to EMA for Gene Therapy of Hemophilia A Zacks
10:16AM  Investors Hope for More From Takeda Than a Healthy Dividend GuruFocus.com
09:45AM  Biogen Ends Enrollment in Eye Disorder Study on Gene Therapy Zacks
01:19AM  Roche extends offer deadline for Spark Therapeutics again Reuters
Nov-11-19 07:37AM  7 Philadelphia-area companies make Deloitte fastest-growing list American City Business Journals
Oct-29-19 03:26PM  For the eighth time, Roche extends $4.3B tender offer for Spark Therapeutics American City Business Journals
10:32AM  Will Spark Therapeutics (ONCE) Report Negative Q3 Earnings? What You Should Know Zacks
Oct-25-19 04:26PM  Why Roche's Acquisition Of Spark May Be Complete By Year's End Investor's Business Daily
09:54AM  Spark Therapeutics Wins Prix Galien USA Award for LUXTURNA® (voretigene neparvovec-rzyl) as Best Biotechnology Product GlobeNewswire
Oct-24-19 06:07PM  FTC staff recommends approval of Roche deal for Spark: report Reuters +7.52%
05:24PM  Gene Therapy Stocks Rocket On Rumor Roche Clinched Its Spark Buyout Investor's Business Daily
10:57AM  Hedge Funds Have Never Been This Bullish On Spark Therapeutics Inc (ONCE) Insider Monkey
Oct-22-19 02:58AM  U.K.s Competition watchdog opens probe into Roche takeover of Spark Therapeutics MarketWatch
Oct-17-19 11:16AM  Roche Posts Solid Sales for First 9 Months of '19, Ups View Zacks
Oct-16-19 01:48AM  UPDATE 2-Roche lifts 2019 sales view again as Chinese demand soars Reuters
Oct-01-19 09:32AM  Seventh time a charm? Roche extends $4.3B Spark tender offer once again American City Business Journals
Sep-30-19 08:50AM  Roche's (RHHBY) Rituxan Receives FDA Nod for Label Expansion Zacks
01:13AM  Roche extends Spark offer again as regulatory review drags on Reuters
Sep-18-19 07:30AM  Paralympic Skier Danelle Umstead Teams Up with Spark Therapeutics to Help People Living with Inherited Retinal Diseases (IRDs) Access Genetic Testing GlobeNewswire
Sep-10-19 12:01AM  Philadelphia Immuno-oncology company Imvax hires CEO American City Business Journals
Sep-06-19 03:07PM  ETFs Poised to Benefit from Gene Editing Revolution Zacks
11:49AM  UPDATE 1-Roche CEO touts drugs pipeline, rules out M&A just to boost sales Reuters
11:09AM  Roche CEO touts drugs pipeline, rules out M&A just to boost sales Reuters
Sep-03-19 10:44AM  Companies to Watch: Roche gets more time for Spark deal, AstraZeneca shows promise in clinical trial, Snap get upgraded Yahoo Finance
10:26AM  Companies to Watch: Roche gets more time for Spark deal, AstraZeneca shows promise in clinical trial, Snap get upgraded Yahoo Finance Video
09:54AM  $4.3B deal delayed again: Roche extends Spark Therapeutics offer for sixth time American City Business Journals
01:39AM  Roche, Spark again extend $4.3 billion takeover offer Reuters
01:28AM  Roche, Spark again extend $4.3 billion takeover offer Reuters
Aug-27-19 07:30AM  Spark Therapeutics Announces Change of Location for Annual Meeting of Stockholders GlobeNewswire
Jul-31-19 10:35AM  Tender offer deadline in $4.3B Roche-Spark deal pushed back for a fifth time. American City Business Journals
07:06AM  The Daily Biotech Pulse: Roche-Spark Deal Faces Further Delay, Bayer's Prostate Cancer Drug Passes FDA Muster Benzinga
01:15AM  Roche, Spark extend $4.3 billion takeover again, this time to September 3 Reuters
Jul-30-19 10:38AM  Analysts Estimate Spark Therapeutics (ONCE) to Report a Decline in Earnings: What to Look Out for Zacks
Jul-25-19 07:25AM  Roche (RHHBY) 1H19 Earnings & Sales Up Y/Y, View Raised Zacks
Jul-17-19 03:22PM  The Multibillion-Dollar Race for Gene Therapy Manufacturing Is On Motley Fool
Jul-11-19 05:33AM  Sangamo Up As Gene Therapy Shows Promise in Hemophilia Study (Revised) Zacks
Jul-09-19 05:52PM  Roche Reveals New Hemlibra Data, Extends Spark Merger Deadline Zacks
11:07AM  Sangamo Up As Gene Therapy Shows Promise in Hemophilia Study Zacks
10:40AM  BioMarin (BMRN) to File for Hemophilia A Candidate in Q4 Zacks
Jul-08-19 03:57PM  Spark, Roche extend deadline for completing $4.3 billion merger into early 2020 American City Business Journals
11:09AM  Roche, Spark push back takeover deadline in $4.3 billion deal Reuters
09:37AM  UPDATE 1-Roche, Spark push back takeover deadline in $4.3 bln deal Reuters
Jun-25-19 09:33AM  Despite Recent Volatility, Biotech Stocks Look Poised to Pop Investopedia
Jun-18-19 03:18PM  IQ merger arbitrage ETF bets on strong M&A space Yahoo Finance Video
Jun-17-19 04:21PM  Why This Gene Therapy Stock Looks Like A Sure Takeover Bet: Analyst Investor's Business Daily
Jun-10-19 04:22PM  Roche's $4.8 Billion Buyout Of Spark Delayed Amid Competitive Worries Investor's Business Daily -8.36%
02:43PM  Roche Extends Deadline For Spark Acquisition As US, UK Regulators Seek Additional Information Benzinga
11:01AM  Spark Therapeutics' Shares Fall on Roche Acquisition Delay TheStreet.com
10:24AM  Roche's $4.8 Billion Buyout Of Spark Delayed Amid Competitive Worries Investor's Business Daily
10:09AM  $4.8 billion deal for gene therapy pioneer Spark Therapeutics delayed once more American City Business Journals
09:39AM  Roche Receives FTC Request for Further Data on Spark Buyout Zacks
07:50AM  UPDATE 1-Roche's $4.3 bln Spark bid delayed again amid U.S., UK scrutiny Reuters
05:08AM  Roches $5bn Spark acquisition held up as regulators seek details Financial Times
02:07AM  Roche's $4.3 billion Spark bid delayed again amid U.S., UK scrutiny Reuters
Jun-07-19 01:25PM  Hedge Funds Have Never Been This Bullish On Spark Therapeutics Inc (ONCE) Insider Monkey
Jun-05-19 07:36AM  BIO 2019 panel: Gene therapy surging, but challenges remain American City Business Journals
Jun-04-19 03:18PM  The 10 Best Stocks for 2019 So Far InvestorPlace
06:56AM  BIO 2019: Philadelphia-area industry leaders put on a life sciences sales pitch for the region American City Business Journals
May-30-19 07:29AM  Spark CEO Marrazzo: Philadelphia will shine at BIO 2019 American City Business Journals
May-28-19 08:44AM  Options Traders Expect Huge Moves in Spark Therapeutics (ONCE) Stock Zacks
May-27-19 06:48AM  Roche Gets FDA Nod for Expansion of Cobas 6800/8800 Systems Zacks
May-26-19 09:00AM  Sandell Asset Managements Latest Moves Insider Monkey
May-24-19 02:34PM  Magnetar Capitals Latest Moves Insider Monkey
May-20-19 07:23PM  Prem Watsa Buys Buffett's Red Hat, Boosts Micron in 1st Quarter GuruFocus.com
May-16-19 04:14AM  Adage Capital Managements Latest Portfolio Moves Insider Monkey
May-14-19 09:50AM  $4.8B Roche-Spark deal delayed, once again American City Business Journals
01:28AM  Roche pushes back Spark takeover again as regulatory review drags on Reuters
01:01AM  Roche and Spark Therapeutics, Inc. announce expected refiling date of Premerger Notification and Report Forms under the HSR Act and extension of tender offer for shares of Spark Therapeutics, Inc. GlobeNewswire
May-07-19 10:30AM  Will Spark Therapeutics (ONCE) Report Negative Q1 Earnings? What You Should Know Zacks
May-03-19 05:31PM  Mario Gabelli's Top 7 Buys of the 1st Quarter GuruFocus.com
May-02-19 11:57AM  Did Hedge Funds Drop The Ball On Spark Therapeutics Inc (ONCE) ? Insider Monkey
Apr-26-19 11:16AM  Roche extends $4.8B Spark tender offer deadline for second time American City Business Journals
08:02AM  The Daily Biotech Pulse: Mixed Results For Merck's Keytruda In Stomach Cancer; Roche's Spark-Buy Delayed, Teva Recalls Hypertension Drug Benzinga
02:23AM  Roche faces further delay in $4.3 billion Spark deal amid FTC review Reuters
02:20AM  Roche faces further delay in $4.3 bln Spark deal amid FTC review Reuters
02:02AM  Roche again extends $4.3 blillion offer for Spark amid FTC review Reuters
01:01AM  Roche and Spark Therapeutics, Inc. announce withdrawal and refiling of Premerger Notification and Report Form under the HSR Act and extension of tender offer for shares of Spark Therapeutics, Inc. GlobeNewswire
Apr-18-19 10:29AM  Roche's (RHHBY) Q1 Sales Strong on Solid Demand for New Drugs Zacks
Apr-17-19 07:30AM  Spark Therapeutics Announces Sponsorship of Believe Limiteds First-Ever Science Fair for the Hemophilia Community at 2019 National Hemophilia Foundations Bleeding Disorders Conference GlobeNewswire
05:03AM  Swiss drugmaker Roche ups outlook as sales growth offsets price hit Reuters
Apr-15-19 03:38PM  Spark Therapeutics (ONCE) Merger Class Action Lawsuit: Halper Sadeh LLP Announces Filing of Shareholder Class Action Lawsuit Against Spark Therapeutics, Inc. Concerning Its Proposed Merger With Roche Holdings, Inc. ONCE GlobeNewswire
08:43AM  Want an insiders way to play IPOs? This fund has had outsize success with its strategy MarketWatch
Apr-12-19 10:02AM  Ophthotech Gets Rights to Gene Therapy for BEST Disease Zacks
Apr-11-19 03:33PM  Biotechnology Market on a Tear: 5 ETFs in Spotlight Zacks
Apr-09-19 02:52PM  COMPLAINTS FILED - ELLI and ONCE: Levi & Korsinsky, LLP Reminds Investors of Complaints Filed Concerning the Sale of these Companies ACCESSWIRE
Apr-08-19 09:45AM  4 Gene Therapy Players Likely to Become Buyout Targets in 2019 Zacks
Apr-05-19 08:00AM  Health Day Checkup of Medical ETFs: 5 Top Picks Zacks
Apr-04-19 11:00PM  Rigrodsky & Long, P.A. Files Class Action Suit Against Spark Therapeutics, Inc. GlobeNewswire
Spark Therapeutics, Inc. focuses on the development of gene therapy products for patients suffering from debilitating genetic diseases. Its products include LUXTURNA (voretigene neparvovec) for the treatment of patients with confirmed biallelic RPE65 mutation-associated retinal dystrophy and viable retinal cells. The company's gene therapy product candidates comprise SPK-8011 and SPK-8016 for hemophilia; SPK-7001 for choroideremia; and SPK-9001 for hemophilia B. It is also developing other liver-directed gene therapies, including SPK-3006 for Pompe disease; and neurodegenerative disease product candidates to address Huntington's disease and others, as well as TPP1 deficiency, which is a form of Batten disease. The company's preclinical programs targets inherited retinal diseases, including Stargardt's disease. The company has collaboration agreement with Pfizer, Inc. for the development and commercialization of SPK-FIX product candidates in its gene therapy program for the treatment of hemophilia B. It also has licensing and commercialization agreement with Novartis to develop and commercialize voretigene neparvovec outside the United States. Spark Therapeutics, Inc. was founded in 2013 and is headquartered in Philadelphia, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
La Barge JosephChief Legal OfficerMar 25Option Exercise55.5795,0035,278,87465,596Mar 27 07:20 PM
Faga DanielChief Business OfficerMar 25Option Exercise41.25102,7504,238,29384,032Mar 27 07:18 PM
High Katherine ASee RemarksMar 21Option Exercise38.20188,1247,186,318326,067Mar 25 04:36 PM
La Barge JosephChief Legal OfficerMar 19Option Exercise20.2512,559254,32821,482Mar 21 08:49 PM
Marrazzo Jeffrey DChief Executive OfficerMar 15Option Exercise3.4549,940172,293355,215Mar 19 05:26 PM
Children's Hospital of Philade10% OwnerFeb 27Sale113.002,000,000226,000,0001,954,957Mar 01 04:18 PM
Mehra AnandDirectorJan 04Option Exercise3.4537,203128,35038,703Jan 08 04:30 PM
Marrazzo Jeffrey DChief Executive OfficerDec 28Option Exercise3.456,00020,700299,354Jan 02 05:12 PM